Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

The document concludes that more research is needed to fully understand the causes of PCOS.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Finasteride helps induce ovulation in nonresponder PCOS women.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

High levels of cortisol in hair are linked to a greater risk of brain aneurysm rupture.

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

PCOS is a major cause of infertility in women of childbearing age.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Pregnancy can cause various skin changes and diseases, requiring careful treatment to protect the baby.

Women with PCOS have higher oxidative stress and hormone imbalances, suggesting managing oxidative stress could help.